Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma. (2021)
Attributed to:
United Kingdom Refractory Asthma Stratification Programme (RASP-UK)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202104-1040le
PubMed Identifier: 34129808
Publication URI: http://europepmc.org/abstract/MED/34129808
Type: Journal Article/Review
Volume: 204
Parent Publication: American journal of respiratory and critical care medicine
Issue: 6
ISSN: 1073-449X